Undeterred by Sanofi stumble, Takeda takes similar path with dengue shot Medical Dialogues Bureau31 Jan 2019 9:00 AM ISTThe strategy mirrors one used by Sanofi SA, which licensed the world's first dengue vaccine, Dengvaxia, in endemic markets in 2015 before attempting...
Strides to exit investment in Arrow Pharma for over Rs 2000 crore Medical Dialogues Bureau30 Jan 2019 9:30 AM IST"Strides will receive AUD 300 million as upfront payment at the closure of the transaction, while the balance AUD 94 million to be deferred through a...
U.S. senator asks J&J for documents on talc, baby powder safety Medical Dialogues Bureau30 Jan 2019 9:15 AM ISTThe letter addressed to J&J Chief Executive Alex Gorsky asks for documents and information related to testing of its talc products for the...
Novartis sees 2019 growth as it sheds eyecare unit, narrows focus Garima30 Jan 2019 9:00 AM ISTNovartis said sales of its Entresto heart failure medicine accelerated along with revenue from its psoriasis-and-arthritis blockbuster...
Cipla gets USFDA nod for Medroxyprogesterone injectable Farhat Nasim29 Jan 2019 11:03 AM ISTThe company has received final approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA)...
Dr. Reddy's gets USFDA approval for TOSYMRA for treatment of migraine Medical Dialogues Bureau29 Jan 2019 9:45 AM ISTTOSYMRA is indicated for the acute treatment of migraine with or without aura in adults. TOSYMRA is the latest product to join the Promius Pharma...
Zydus Wellness to sell shares worth Rs 2575 crore to Cadilla and three others Medical Dialogues Bureau29 Jan 2019 9:20 AM ISTIn a tweet Friday, the Competition Commission of India (CCI) said it "approves the acquisition of shares in Zydus Wellness Limited by True North...
Exclusive: CVS to cover migraine drugs from Teva, Lilly; excludes Amgen Medical Dialogues Bureau29 Jan 2019 9:00 AM ISTThe move by CVS is a positive development for Teva, whose drug was initially excluded from the list of covered drugs by Express Scripts, another large...
Lupin gets 6 observations from USFDA for its Pithampur Unit-2 Medical Dialogues Bureau28 Jan 2019 1:20 PM ISTNEW DELHI: Drug firm Lupin Saturday said the US health regulator has issued six observations after the inspection of a unit of its Pithampur facility...
Price Ceiling, Compulsory licensing of patented medicines Necessary: Govt panel Medical Dialogues Bureau28 Jan 2019 12:50 PM ISTWorried about "high prices" and "unaffordability" of patented medicines in India, the Department of Pharmaceuticals (DOP) formed this...
Aurobindo recalls nearly 5 lakh bottles of blood pressure drug in US Medical Dialogues Bureau28 Jan 2019 12:41 PM ISTNew Delhi: Drug firm Aurobindo is recalling close to 5 lakh bottles of blood pressure lowering drugs in the US after the American health regulator...
Glenmark Pharma gets tentative ANDA approval for Topiramate Extended-Release Capsules Medical Dialogues Bureau28 Jan 2019 9:00 AM ISTMumbai: Glenmark Pharma said that it US subsidiary Glenmark Pharmaceuticals Inc., USA has been granted tentative approval by the United States Food...
